A report just published in the Journal of the National Cancer Institute adds more evidence to the importance of insulin regulation in ER (estrogen receptor) negative breast cancer. The authors first note a conundrum in breast cancer epidemiology:

“Body mass index is inversely associated with risk of premenopausal breast cancer, but the underlying mechanisms for this association are poorly understood. Abdominal adiposity is associated with metabolic and hormonal changes, many of which have been associated with the risk of premenopausal breast cancer.”

They investigated the association between body fat distribution, hip circumference, and waist to hip ratio, and the incidence of premenopausal breast cancer in the Nurses’ Health Study II:

“During 426 164 person-years of follow-up from 1993 to 2005, 620 cases of breast cancer were diagnosed among 45 799 women. Hormone receptor status information was available for 84% of the breast cancers.”

When they looked at the group as a whole, no statistically significant associations were found. However…

“…each of the three body fat distribution measures was statistically significantly associated with greater incidence of estrogen receptor (ER)–negative breast cancer.”

The risk for ER-negative breast cancer was increased by 275% for waist circumference, 240% for hip circumference, and 195% for waist to hip ratio (comparing the highest to the lowest quintile). The authors state:

“These findings may suggest that an insulin-related pathway of abdominal adiposity is involved in the etiology of premenopausal breast cancer.“

The implication is that factors associated with increased abdominal adiposity influence the development of breast cancer through estrogen independent pathways, specifically the influence of excess levels of insulin on tumor growth that also promote the accumulation of fat around the waist. As experienced clinicians know, tumors often have mixed cell types. The role of insulin as a tumor promoter should never overlooked in case management, with careful attention to the regulation of blood sugar and insulin.

-

More research recently published in the Archives of Internal Medicine further validates the power of waist circumference measurements to predict death from all causes. This study provides evidence that its accuracy is far superior to body mass index (BMI).

“Waist circumference (WC), a measure of abdominal obesity, is associated with higher mortality independent of body mass index (BMI). Less is known about the association between WC and mortality within categories of BMI or for the very high levels of WC that are now common.”

The authors examined the association between WC and mortality among 48 500 men and 56 343 women between 1997 and 2006, during which 9315 men and 5332 women died. Considering the adverse metabolic and hormonal activity of visceral (intra-abdominal versus subcutaneous) fat, their data is not surprising:

“After adjustment for BMI and other risk factors, very high levels of WC were associated with an approximately 2-fold higher risk of mortality in men and women…The WC was positively associated with mortality within all categories of BMI.”

Very high levels of WC means 47 inches for men and 43 inches for women. Waist circumference is a more reliable indicator than weight or BMI. If you’re losing weight without your WC getting smaller, you’re probably losing more muscle than fat. As the authors state in their conclusion:

“These results emphasize the importance of WC as a risk factor for mortality in older adults, regardless of BMI.”

-

Factors that place fat around the waist (insulin resistance) and the activity of that fat tissue (production of signaling molecules that promote inflammation) are both at play behind the connection documented recently in this paper published in the journal Neurology. The authors found that “…a midlife WHR [waist hip ratio] greater than 0.80 increased risk for dementia approximately twofold…,” and conclude: “There are midlife and late-life implications for dementia prevention, and analytical considerations related to identifying risk factors for dementia.” Here are a few more papers related to the same finding:

1. Research on diabetes, hyperinsulinemia and dementia in Dementia and Geriatric Disorders
2. A paper on abdominal obesity and Alzheimer Disease published in the same journal
3. A study in Archives of Neurology that concludes: “A larger WHR may be related to neurodegenerative, vascular, or metabolic processes that affect brain structures underlying cognitive decline and dementia.”

-

Here is more evidence of the strong correlation between erectile dysfunction and insulin. This paper recently published in the Journal of Andrology clearly discerns  the “correlation between erectile function and IR and abdominal obesity.” [IR = insulin resistance. Waist circumference is a metric for abdominal obesity.] Moreover, “IR also appears to alter testosterone production.” Important: a careful reading of this paper also discloses what functional medicine practitioners and Lapis Light patients know: “a negative correlation [with erectile function] was shown only between BT (biologically active fraction) and abdominal obesity. (BT is also termed free-fraction testosterone, measured in our salivary profiles. Total testosterone is not a reliable indicator.)

-

Phytochemicals occur naturally in plants, especially richly colored vegetables and fruits. This interesting study reports that a Phytochemical Index (PI), derived from the proportional amount of phytochemical-rich foods in the subjects’ diets, correlated with weight-gain, waist circumference, waist-to-hip ratio and plasma oxidative stress (linked to inflammation). “The PI score was a significant contributor to yearly weight gain.” This confirms an additional benefit from a diet whose carbohydrate portion is mainly from low-glycemic vegetables and fruits.

-